Table 1.
Representative nanomaterials used as PTT agents in combination therapies.
Nanomaterials | Combination Therapy | Mechanism | Ref. |
---|---|---|---|
CP-TPP/Au/PEG nanospheres | PTT + PDT | LTH (808 nm) and ROS (630 nm) | [55] |
GNc-HyNA | PTT + PDT | LTH (808 nm) and ROS (690 nm) | [56] |
GNS-PEG-Ce6 | PTT + PDT | LTH (671 nm) and ROS (671 nm) | [57] |
Te-NDs | PTT + PDT | LTH and ROS (785 nm) | [58] |
UCNPs-NGO/ZnPC | PTT + PDT | LTH (808 nm) and ROS (630 nm) | [59] |
CDAuNs | PTT + CT | LTH (808 nm) and CDR | [60] |
DINPs | PTT + CT | LTH (808 nm) and CDR | [61] |
HPSN-Pax/PdPc | PTT + CT | LTH (730 nm) and CDR | [62] |
Polydopamine-rGO-MSN | PTT + CT | LTH (808 nm) and CDR | [63] |
Polypyrrole@MIL-100/DOX | PTT + CT | LTH (808 nm) and CDR | [64] |
HCuSNPs-CpG | PTT + IT | LTH (900 nm) and SI using small-molecule inhibitors |
[65] |
OVA-ICG | PTT + IT | LTH (808 nm) and SI as cancer vaccine |
[66] |
PCN | PTT + IT | LTH (808 nm) and SI as immune agonists |
[67] |
PEGylated SWNT | PTT + IT | LTH (808 nm) and SI as immune checkpoint blockades |
[68] |
piTRLs | PTT + IT | LTH (808 nm) and SI using immunostimulant |
[69] |
CSA | PTT + RT | LTH (808 nm) and X-ray | [54] |
Dox-HGNP | PTT + RT | LTH (800 nm) and X-ray | [70] |
mPEG@HGNPs | PTT + RT | LTH (808 nm) and X-ray | [71] |
PtNP | PTT + RT | LTH (808 nm) and X-ray | [72] |
WS2QDs | PTT + RT | LTH (808 nm) and X-ray | [73] |
Abbreviations: CDAuNS: cancer cell membrane-coated doxorubicin-incorporated gold nanocages, CDR: chemo drug release, CpG: cytosine-guanine, CP-TPP: poly(cyclotriphosphazene-co-tetraphenylporphyrin-co-sulfonyldiphenol) nanospheres, CSA: dumbbell-shaped heterogeneous copper selenide-gold nanoparticles, CT: chemotherapy, DINP: PLGA-lecithin-PEG NPs containing DOX and ICG, DOX: doxorubicin, Dox-HGNP: doxorubi-cin-loaded hollow gold nanoparticle, GNc-HyNA: gold-nanoclustered hyaluronan nanoassembly, GNS-PEG-Ce6: chlorin e6-conjugated gold nanostars, GO-PEG-PEI-Ure B: PEG and PEI modified graphene oxide containing urease B, HCuSNPs: hollow Cus nanoparticle, HGNP: hollow gold nanoparticles, HPSN: hollow structured polymer-silica nanohybrid, ICG: indocyanine green, IT: immunotherapy, LTH: light-triggered hyperthermia, NGO: nanographene oxide, OVA: ovalbumine, Pax/PdPc: paclitaxel and palla-dium phthalocyanine, PCN: CpG-integrated OVA@Au nanorod, PEG: polyethylene glycol, PEG-[64Cu]CuS NPs: Copper 64 tagged PEG-coated copper sulfide nanoparticles, piTRLs: poly I:C- and ICG containing thermal responsive liposomes, PLGA: poly(lactic-co-glycolic acid), PtNP: platinum nanoparticles, PTT: photothermal therapy, RT: radiotherapy, ROS: reactive oxygen species generation, SI: stimulation of immune system, SWNT: single-walled carbon nanotubes, Te-NDs: tellurium nanodots, TNP-1: copper-palladium alloy tetrapod nanoparticles, UCNPs: upconversion nanoparticles, WS2QDs: tungsten sulfide quantum dots, X-ray: X-ray irradiation, ZnPc: zinc phthalocyanine.